Search filters

List of works by Amir Sharabi

A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide

scientific article published on 16 September 2009

A novel tolerogenic peptide, hCDR1, for the specific treatment of systemic lupus erythematosus.

scientific article published on 23 July 2010

A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide

scientific article published on 25 August 2010

A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.

scientific article

A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 mice

scientific article published on 23 July 2009

Altered gene expression in mice with lupus treated with edratide, a peptide that ameliorates the disease manifestations

scientific article published on 01 July 2007

Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK

scientific article published on 27 October 2005

Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide.

scientific article published in December 2009

Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosis

scientific article published on 28 February 2006

B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus

scientific article published in February 2009

Bcl-xL affects the development of functional CD4 Tregs

scientific article published on 23 July 2010

Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide

article

Breaking tolerance in a mouse model of multiple myeloma by chemoimmunotherapy.

scientific article published on January 2010

Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model

article

Editorial: Molecules Balancing Immunological Surveillance against Cancer and Autoimmune Diseases.

scientific article

Empowering Regulatory T Cells in Autoimmunity

scientific article

Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.

scientific article published on 06 April 2011

In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in mice

scientific article

Induced Sputum Analysis in Subjects With Systemic Sclerosis

scientific article published on 7 June 2016

Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations

scientific article published on 03 December 2010

Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.

scientific article

PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.

scientific article published on 26 March 2019

Precision DNA demethylation ameliorates disease in lupus-prone mice

scientific article published on 23 August 2018

Regulatory T cells in the treatment of disease

scientific article published on 12 October 2018

Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route ⬇️

scientific article published on December 1, 2003

Rituximab as a Second-Line Treatment for Lymphocytic Vasculitis of the Central Nervous System

scientific article published in October 2016

The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study

scientific article published in June 2016

The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model.

scientific article

The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models

scientific article published on 24 November 2008

The serine/threonine protein phosphatase 2A controls autoimmunity.

scientific article published on 20 July 2017

The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells

scientific article published on 01 September 2008

The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients

scientific article published in March 2009

The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosus.

scientific article

Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression

scientific article published on 5 April 2009

Paulina is supported by:

About Paulina

Help